Albumin nanospheres as carriers for passive drug targeting: An optimized manufacturing technique

Pharmaceutical Research

Volumn 13, Issue 1, 1996, Pages 32-37

  Müller, Bernhard G ^a,b,d   Leuenberger, Hans ^b   Kissel, Thomas ^c  

^a Sandoz Pharma Ltd   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Albumin; Central composite design; Cross linking; Glutaraldehyde; Manufacturing; Nanospheres

Indexed keywords

ALBUMIN; DRUG CARRIER; GLUTARALDEHYDE; NANOPARTICLE;

ARTICLE; CROSS LINKING; DISPERSION; DRUG DELIVERY SYSTEM; DRUG TARGETING; EMULSION; METHODOLOGY; PARTICLE SIZE; PRIORITY JOURNAL;

CROSS-LINKING REAGENTS; DRUG CARRIERS; DRUG INDUSTRY; EMULSIONS; MICROSPHERES; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN, BOVINE; SOLUBILITY; WATER;

EID: 0029867284     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016064930502     Document Type: Article

References (13)

1. P.K. Gupta and C.T. Hung. Albumin microspheres II: applications in drug delivery. J. Microencapsulation 6: 463-472 (1989).
2. L. Illum, S.S. Davis, C.G. Wilson, N. Thomas, M. Frier and J.G. Hardy. Blood clearance and organ deposition of intravenously administered colloidal particles: the effects of particle size, nature and shape. Int. J. Pharm. 12: 135 (1982).
3. E. Tomlinson, J.J. Burger. Monolithic albumin particles as drug carriers. In: L. Illum, J.G. McVie and E. Tomlinson (eds.), Polymers in Controlled Drug Delivery, Wright, Bristol, 1987, pp. 25-48.
4. B.G. Müller and T. Kissel. Camouflage nanospheres: a new approach to bypassing phagocytic blood clearance by surface modified particulate carriers. Pharm. Pharmacol. Lett. 3: 67-70 (1993).
5. R. Arshady. Albumin microspheres and microcapsules: methodology of manufacturing techniques. J. Controlled Release 14: 111-131 (1990).
6. M. Roser and T. Kissel. Surface-modified biodegradable albumin nano- and microspheres: I. Preparation and characterization. Eur. J. Biopharm. 39: 8-12 (1993).
7. N. Ostrowski. Particle characterization by photon correlation spectroscopy. In P.J. Lloyd (ed.), Particle Size Analysis 1988. John Wiley, Chichester, 1988.
8. E. Tomlinson and J.J. Burger. Incorporation of water-soluble drugs in albumin microspheres. In K.J. Widder and R. Green (eds.), Methods in Enzymology, Academic Press, Orlando, 1985, pp. 27-42
9. H. Leuenberger. Mathematische Versuchsplanung und Optimierungsstrategien. In H. Sucker, P. Fuchs and P. Speiser (eds.), Pharmazeutische Technologie, Georg Thieme Verlag, Stuttgart, 1991.
10. Statgraphics (Release 5.22), STSC Inc., Rockville, USA.
11. G.E.P. Box, N.R. Draper. Empirical Model-Building and Response Surfaces, Wiley, New York, 1987.
12. G. Derringer and R. Suich. Simultaneous Optimization of Several Response Variables. J. Quality Technology 12: 214-219 (1980).
13. J.J. Torrado, L. Illum and S.S. Davis. Particle size and size distribution of albumin microspheres produced by heat and chemical stabilization. Int. J. Pharm. 51: 85-93 (1989).